Ng WW, Lin CC, Cheng CY, Jiang JS, et al. Real-world outcomes of first- and second-generation tyrosine kinase inhibitors first-line in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer: A retrospective observational cohort study. PLoS One 2021;16:e0253335.
PMID: 34166400